Vertex pharmaceuticals incorporated reiterates revenue guidance for the full year 2019

Vertex pharmaceuticals incorporated reiterated revenue guidance for the full year 2019. for the year, the company reiterated its 2019 revenue guidance that was updated on october 21, 2019. the company now expects total product revenues unchanged from the previous guidance of $3.70 billion to $3.75 billion.
VRTX Ratings Summary
VRTX Quant Ranking